Total Funding
38
49
Total FundingSeed raised
Growth Score
2 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
210270
Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections.
Eric Broyles: Co-Founder, CEO, and President- Jacques P. Walker: Co-Founder
About the Company
Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections. The company leverages nanotechnology to create solutions for hard-to-cure indications where current interventions are insufficient. Through the application of nanotechnology to medicine, Nanocan aims to help improve
the quality of life of our patients, increase access to medicine and other treatments, and to reduce global health disparities.
